GSK Says Moderna's COVID, RSV Vax Infringe MRNA Patents
Moderna's breakthrough COVID-19 vaccine and a related聽respiratory syncytial virus, or RSV, vaccine聽were built on mRNA technology discovered by researchers whose patents are owned by GlaxoSmithKline, the latter company alleged in a...To view the full article, register now.
Already a subscriber? Click here to view full article